Apollo Commercial Real Estate Finance (ARI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Mar, 2026Executive summary
A special meeting is scheduled for April 21, 2026, to vote on the sale of the commercial real estate loan portfolio to Athene Holding Ltd., the issuance of common stock to the manager in lieu of cash, and potential adjournment of the meeting if more votes are needed.
The Asset Sale involves selling nearly all commercial real estate loans, excluding two loans expected to be repaid before closing, for 99.7% of the total commitment amount, paid in cash.
The board, following a unanimous special committee recommendation, urges shareholders to vote in favor of all proposals, citing strategic flexibility and value creation.
If approved, the company expects to have $1.4 billion in net cash and $1.7 billion in equity post-transaction, with plans to evaluate new investment strategies or strategic alternatives by year-end.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the Asset Sale Proposal, (2) the Common Stock Issuance Proposal, and (3) the Adjournment Proposal.
Approval of the Asset Sale requires a majority of all votes entitled to be cast; the stock issuance and adjournment proposals require a majority of votes cast.
Failure to vote or abstentions count as votes against the Asset Sale Proposal but not the other proposals.
The board recommends voting “FOR” all proposals.
Board of directors and corporate governance
The special committee, composed of independent and disinterested directors, led the negotiation and evaluation process.
Two directors with Apollo affiliations recused themselves from voting on the Asset Sale.
The board considered strategic alternatives, including mergers and asset sales, before recommending the Athene transaction.
Latest events from Apollo Commercial Real Estate Finance
- Shareholders will vote on dissolving the company and liquidating assets, with estimated payouts up to $8.50 per share.ARI
Proxy filing14 Jul 2026 - Q4 net income was $0.27/share, but full-year loss was ($0.97); $2.5bn redeployed into new loans.ARI
Q4 20249 Jul 2026 - Q1 2025 saw strong earnings, robust loan growth, and expanded credit capacity.ARI
Q1 20258 Jul 2026 - Q3 net income was $48M with $1B in new loans and strong liquidity for future growth.ARI
Q3 20258 Jul 2026 - Board seeks stockholder approval for dissolution and liquidation, with a $3.75 dividend declared.ARI
Proxy filing16 Jun 2026 - Annual meeting to elect directors, ratify auditor, and hold a say-on-pay vote, with digital voting options.ARI
Proxy filing29 May 2026 - Annual meeting to vote on directors, auditor, and executive pay, with key governance updates.ARI
Proxy filing29 May 2026 - Q1 2026 net income was $23.2M; major loan sale enabled full debt repayment and capital return.ARI
Q1 202629 Apr 2026 - $8.8B loan portfolio, 9.4% yield, and robust Apollo backing drive strong performance.ARI
Investor presentation9 Mar 2026